Tekla Life Sciences Inves... (HQL)

AI Score

Unlock

11.80

0.14 (1.20%)

At close: Apr 17, 2025, 3:59 PM

11.78

-0.19%

After-hours: Apr 17, 2025, 04:25 PM EDT

Tekla Life Sciences Investors Income Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021	Mar 31, 2021	Sep 30, 2020	Mar 31, 2020	Sep 30, 2019	Mar 31, 2019	Sep 30, 2018	Mar 31, 2018	Sep 30, 2017	Mar 31, 2017	Sep 30, 2016	Mar 31, 2016
Revenue	3.98M	31.63M	31.49M	23.62M	31.86M	26.15M	45.01M	45.53M	39.07M	23.89M	2.44M	2.12M	1.99M	997.95K	1.68K	1.51K	1.44K	1.55K
Cost of Revenue	n/a	2.59M	2.59M	2.64M	5.55M	6.01M	6.08M	5.69M	5.21M	2.48M	n/a	n/a	n/a	4.82M	4.82M	n/a	n/a	n/a
Gross Profit	3.98M	29.04M	28.9M	20.98M	26.31M	20.14M	38.94M	39.84M	33.87M	21.4M	2.44M	2.12M	1.99M	-3.82M	-4.82M	1.51K	1.44K	1.55K
Operating Income	-1.92M	-12.1M	-12.39M	-29.25M	-104.61M	-43.33M	64.53M	124.43M	123.06M	28.87M	-2.88M	-3.39M	-3.61M	-1.78M	-3.88K	-3.54K	-3.79K	-4.37K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	85.3M	38.81M	22.35M	5.5M	-104.6M	-43.31M	64.53M	124.41M	123.05M	-1.18M	-70.48M	9.3M	28.66M	-19.7M	68.55K	84.17K	-11.91K	-119.85K
Net Income	85.3M	38.81M	22.35M	5.5M	-104.6M	-43.31M	64.53M	124.41M	123.05M	-1.18M	-70.48M	9.3M	28.66M	-19.7M	68.55K	84.17K	-11.91K	-119.85K
Selling & General & Admin	5.9M	2.72M	2.87M	4.31M	1.44M	3.21K	3.21K	3K	2.75K	2.63M	5.32M	5.5M	5.59M	2.78M	5.56K	5.05K	5.23K	5.92K
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	-38.42M	-38.42M	-47.35M	-47.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	5.9M	41.14M	41.29M	17.82M	14.98M	54.77K	31.12K	61.04K	59.83K	2.65M	5.32M	5.5M	5.59M	2.82M	66.87K	82.66K	126.66K	121.4K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	30.66M	30.66M	n/a	n/a	n/a	87.73M	87.73M	n/a	n/a	n/a
Selling & Marketing Expenses	24.61K	8.11K	n/a	n/a	n/a	n/a	n/a	n/a	68.45K	68.45K	n/a	n/a	n/a	118.58K	118.58K	n/a	n/a	n/a
Cost & Expenses	5.9M	43.73M	43.88M	52.87M	136.47M	69.48M	-19.51M	-78.9M	-83.99M	-4.99M	5.32M	5.5M	5.59M	2.82M	66.87K	82.66K	126.66K	121.4K
Income Tax Expense	n/a	-43.81K	-43.81K	-651.14K	-651.98K	-1.9K	-2.07K	-1.84K	-1.06K	-232.02	n/a	n/a	n/a	43.86K	72.43K	87.71K	-8.12K	-115.48K
Shares Outstanding (Basic)	28.77M	27.35M	26.79M	26.21M	25.68M	25.14M	24.67M	24.28M	23.75M	23.49M	23.6M	22.76M	22.8M	22.01M	21.57K	21.17K	20.74K	20.12K
Shares Outstanding (Diluted)	28.77M	27.35M	26.79M	26.21M	25.68M	25.14M	24.67M	24.28M	23.75M	23.49M	23.6M	22.76M	22.8M	22.01M	21.57K	21.17K	20.74K	20.12K
EPS (Basic)	3.06	1.41	0.86	0.19	-4.13	-1.69	2.64	5.21	5.20	-0.04	-3.05	0.40	1.22	1.04	3.20	4.02	-0.68	-6
EPS (Diluted)	3.06	1.41	0.86	0.19	-4.13	-1.69	2.64	5.21	5.20	-0.04	-3.05	0.40	1.22	1.04	3.20	4.02	-0.68	-6
EBITDA	100.51M	89.07M	-11.45M	-28.31M	-104.61M	-43.33M	64.53M	124.43M	123.06M	30.19M	n/a	n/a	n/a	43.86K	72.43K	87.71K	-8.12K	-115.48K
EBIT	99.25M	89.07M	-12.39M	-29.25M	-104.61M	-43.33M	64.53M	124.43M	123.06M	28.87M	-2.88M	-3.39M	-3.61M	-3.88M	-3.88M	-3.54M	-3.79M	-4.37M
Depreciation & Amortization	1.92M	697.15K	984.56K	1.59M	651.98K	1.9K	2.07K	1.84K	1.06K	1.32M	2.88M	3.39M	3.61M	1.78M	3.88K	3.54K	3.79K	4.37K